Align Technology, Inc. vs Amplify Transformational Data Sharing ETF — how do they compare? Align Technology, Inc. trades at $173.38 (market cap $12.36B), while Amplify Transformational Data Sharing ETF trades at $59.55. The key difference: Align Technology, Inc. is trading nearer its 52-week high, Amplify Transformational Data Sharing ETF nearer its low. Which is the better fit depends on your goals.
| ALGN | BLOK | |
|---|---|---|
Market Cap | $12.36B | — |
Sector | Health | — |
52-Week High | $197.51 | $74.10 |
52-Week Low | $124.88 | $47.36 |
Enterprise Value | $11.38B | — |
Signals from Pluang's Aura AI — not financial advice
ALGN trades at $174.63, down 0.8% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported strong Q2 2026 earnings, beating estimates with record revenue and clear aligner volume. Fundamentals show solid profitability with a 68.05% gross margin and 9.99% net income margin, though revenue growth has moderated. Recent news highlights a patent win in China and strategic initiatives following activist investor engagement.
The outlook is mixed: analyst consensus is strongly bullish (73% buy ratings), but technicals and slowing revenue growth pose near-term risks. Investment opportunity lies in international expansion and digital dentistry platform growth, while risks include competitive pressures and execution of new strategic initiatives. The stock's valuation at 30x P/E requires sustained earnings growth to justify.
BLOK trades at $60.12, up 1.76% with bearish technical signals from moving averages. The ETF shows mixed sentiment with institutional position adjustments and positive coverage on AI infrastructure exposure. Key support sits at $58-59 while resistance levels begin at $61.
Outlook remains cautious given bearish technical indicators and institutional selling pressure. The fund's diversified blockchain economy exposure offers growth potential but faces volatility risks from sector concentration and regulatory uncertainty.
Trailing returns across standard periods
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →The fund is an actively managed ETF that seeks to provide total return by investing at least 80% of its net assets in the equity securities of companies actively involved in the development and utilization of "transformational data sharing technologies". It may invest in non-US equity securities, including depositary receipts.
Read more on BLOK →